Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori-authors' reply

Affiliations

¹ Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
² Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
³ Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

Editorial

Y S Jung et al. Aliment Pharmacol Ther. 2017 Sep.

. 2017 Sep;46(5):551-552.

doi: 10.1111/apt.14206.

¹ Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
² Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
³ Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

No abstract available

Comment on

Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.
Jung YS, Kim EH, Park CH. Jung YS, et al. Aliment Pharmacol Ther. 2017 Jul;46(2):106-114. doi: 10.1111/apt.14130. Epub 2017 May 12. Aliment Pharmacol Ther. 2017. PMID: 28497487
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori.
Fraser AG. Fraser AG. Aliment Pharmacol Ther. 2017 Sep;46(5):550-551. doi: 10.1111/apt.14198. Aliment Pharmacol Ther. 2017. PMID: 28776748 No abstract available.